Skip to main content
NCBI home page
Neurophotonics logoLink to Neurophotonics
. 2016 Mar 23;3(1):019801. doi: 10.1117/1.NPh.3.1.019801

Errata: Transcranial low-level laser therapy (810 nm) temporarily inhibits peripheral nociception: photoneuromodulation of glutamate receptors, prostatic acid phophatase, and adenosine triphosphate

Marcelo Victor Pires de Sousa a,b,c, Cleber Ferraresi a,d,e,f, Masayoshi Kawakubo a, Beatriz Kaippert a,g, Elisabeth Mateus Yoshimura b, Michael R Hamblin a,h,i
PMCID: PMC4804099  PMID: 27115021

This article [Neurophoton. 3(1), 015003 (2016)] was originally published online on 25 January 2016 with an error in the abstract. The last sentence of the abstract, “This is the first study to show inhibition of peripheral pain due to photobiomodulation of the central nervous system,” is incorrect and has been removed from the paper. Prior published work showed inhibition of peripheral pain due to photobiomodulation of the central nervous system.1

The article was republished online on 16 March 2016 and appears correctly in print.

References

  • 1.Wedlock P. M., Shephard R. A., “Cranial irradiation with GAAiAs laser leads to naloxone reversible analgesia in rats,” Psychological Reports 78, 727–731 (1996). 10.2466/pr0.1996.78.3.727 [DOI] [PubMed] [Google Scholar]

Articles from Neurophotonics are provided here courtesy of Society of Photo-Optical Instrumentation Engineers

RESOURCES